DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock

NYSE · Life Sciences Tools & Services · Ver en SEC EDGAR ↗
$6,78
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 6, 2026

Acerca de Ginkgo Bioworks Holdings, Inc. Class A Common Stock Descripción general de la empresa de Wikipedia

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.

Leer más

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.

History

In 2014, Ginkgo was the first biotechnology company to join the Y Combinator start-up accelerator program.

On 16 December 2020, it was reported that Ginkgo Bioworks would acquire the primary assets of Novogy's Microbial Engineering Platform. 2020 also saw the company acquire property worth $25 million from Marcus Partners for the construction of a new 219,000 square foot laboratory building, after razing existing structures, located in the Raymond L Flynn Marine Park. As of 2021, the company also occupied 200,000 square feet of the Innovation and Design Building (aka IDB) in the Park. Ginkgo also occupied facilities in Cambridge, where most MIT-spin outs resided at the time.

Growth of Ginkgo up to 2021 had been driven by "robust venture capital funding" and entry into the COVID-19 testing market. This included $45 million from Viking Global in 2015.

On 11 May 2021, Ginkgo Bioworks announced plans of going public through a merger with SPAC Soaring Eagle at a $17.5 billion valuation.

On 14 May 2021, Ginkgo announced its new ticker for the NYSE will be "DNA". The ticker was previously used by Genentech, who stopped using the ticker after they were acquired by Roche. Trading began on September 17, 2021. The investment management firm Baillie Gifford became the largest shareholder (15%) with the purchase of 167.75 million shares on 31 March 2022.

On 14 March 2022, it was reported that Ginkgo Bioworks signed a Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform.

On 6 June 2022, it was reported that Ginkgo Bioworks has acquired assets from real-time metabolite monitoring company, Bitome.

On 25 July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million in an all-stock deal.

On 27 July 2022, it was reported that Ginkgo Bioworks would acquire Bayer's Biologics Research & Development site, located in West Sacramento. Ginkgo will enter into a new multi-year platform collaboration with Bayer. The deal includes the integration of the R&D platform assets from Joyn Bio, a joint-venture between Leaps by Bayer investments and Ginkgo Bioworks.

On 4 October 2022, it was reported that Ginkgo Bioworks would acquire France-based adaptive laboratory evolution instruments developer Altar and California-based Circularis to strengthen capabilities in cell and gene therapy.

In October 2022, Bloomberg News reported that Ginkgo Bioworks partnered with Intelligence Advanced Research Projects Activity to create a software tool to help detect when biological organisms have been genetically engineered. The tool known as ENDAR (short for Engineered Nucleotide Detection and Ranking) could be used to provide an early warning of bioweapons and other man-made biological threats.

Fraud allegations

On 6 October 2021, a market research firm published a report accusing Ginkgo of embellishing its revenue in a complex scheme highly dependent on related-party transactions. The report prompted an inquiry into Ginkgo by the United States Department of Justice. In November 2021, Ginkgo was sued in a shareholder lawsuit alleging it misrepresented its revenue sources in statements regarding its merger with a special-purpose acquisition company. As of 2021, the company could not name a single significant product that is manufactured and sold using its organisms.

In March 2023, the former Attorney General of Louisiana launched an investigation into the officers and directors of Ginkgo.

Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗

Wikidata ↗

DNA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

Precio
$6.78
Capitalización Bursátil
$418M
P/E (TTM)
-1.3
BPA (TTM)
$-5.64
Ingresos (TTM)
$170M
Rendimiento div.
ROE
-55.8%
Deuda/Capital
Rango 52S
$5 – $18

DNA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

Ingresos y Beneficio Neto $170M
7-point trend, +214.0%
2019-12-31 2025-12-31
BPA $-5.64
7-point trend, -5540.0%
2019-12-31 2025-12-31
Flujo de caja libre $-179M
4-point trend, +41.3%
2022-12-31 2025-12-31
Márgenes -183.8%

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica
Tendencia a 5 años
DNA
Mediana de Pares
P/E (TTM)
5-point trend, +99.4%
-1.3
17.5
P/S (TTM) (P/V (TTM))
4-point trend, -98.9%
2.5
3.3
P/B (P/C)
4-point trend, -98.7%
0.8
2.1
Price / FCF (Precio / FCF)
4-point trend, +99.4%
-2.3

Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC

Métrica
Tendencia a 5 años
DNA
Mediana de Pares
Operating Margin (Margen Operativo)
4-point trend, +59.9%
-185.3%
Net Profit Margin (Margen de Beneficio Neto)
4-point trend, +58.3%
-183.8%
-56.5%
ROA
4-point trend, +72.6%
-25.1%
-17.2%
ROE
4-point trend, +57.9%
-55.8%
-41.3%
ROIC
4-point trend, +51.1%
-61.8%

Salud financiera Deuda, liquidez, solvencia — solidez del balance general

Métrica
Tendencia a 5 años
DNA
Mediana de Pares
Current Ratio (Ratio corriente)
4-point trend, -41.4%
4.9
4.9
Quick Ratio (Ratio Rápido)
4-point trend, -42.4%
4.7

Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años

Métrica
Tendencia a 5 años
DNA
Mediana de Pares
Revenue YoY (Ingresos interanuales)
5-point trend, -45.8%
-25.1%
Revenue CAGR 3Y (Ingresos CAGR 3A)
5-point trend, -45.8%
-29.1%
Revenue CAGR 5Y (Ingresos CAGR 5A)
5-point trend, -45.8%
17.3%

Métricas por acción BPA, valor contable por acción, flujo de caja por acción, dividendo por acción

Métrica
Tendencia a 5 años
DNA
Mediana de Pares
EPS (Diluted) (BPA (Diluido))
5-point trend, -305.8%
$-5.64

Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar

Métrica
Tendencia a 5 años
DNA
Mediana de Pares

DNA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

VENTA 10 analistas
  • Compra fuerte 0 0,0%
  • Compra 1 10,0%
  • Mantener 2 20,0%
  • Venta 5 50,0%
  • Venta fuerte 2 20,0%

Precio objetivo a 12 meses

2 analistas · 2026-08-15
Objetivo mediano $7.00 +3,3%
Objetivo medio $7.00 +3,3%

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

Sorpresa Media
0.05%
Período EPS Actual EPS est. Sorpresa
30 de junio de 2026 $-0.75 $-0.92 0.17%
31 de marzo de 2026 $-1.39 $-1.09 -0.30%
31 de diciembre de 2025 $-1.41 $-1.47 0.06%
30 de septiembre de 2025 $-1.45 $-1.25 -0.20%
30 de junio de 2025 $-1.10 $-1.58 0.48%
31 de marzo de 2025 $-1.68 $-1.79 0.11%

Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
DNA $484M -1.5 -25.1% -183.8% -55.8%
AZTA $1.32B -23.5 3.5% -9.4% -3.3% 45.5%
CYRX $479M 6.9 12.4% 44.4% 15.3% 47.1%
CTKB $649M 505.0 0.52% -33.0% -18.5% 51.8%
MLAB $489M 73.1 3.4% 2.7% 3.7% 63.5%
OABI
TKNO $204M -11.9 7.3% -42.6% -23.8% 33.2%
PACB $565M -1.0 3.9% -341.5% -1634.9% 28.6%
LAB $495M -6.4 -6.2% -87.8% -17.6% 49.9%
LFCR $249M -5.3 0.47% -30.0% -461.3% 31.3%
CDXS $147M -3.3 18.6% -62.5% -82.8%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

Estado de resultados 15
Datos anuales de Estado de resultados para DNA
Métrica Tendencia 2025202420232022202120202019
Revenue 7-point trend, +214.0% $170M $227M $251M $478M $314M $77M $54M
R&D Expense 7-point trend, +153.1% $244M $424M $581M $1.05B $1.15B $160M $96M
SG&A Expense 7-point trend, +521.7% $183M $246M $385M $1.43B $863M $38M $29M
Operating Expenses 7-point trend, +285.9% $485M $787M $1.12B $2.69B $2.14B $214M $126M
Operating Income 7-point trend, -340.3% $-315M $-560M $-864M $-2.21B $-1.83B $-137M $-72M
Interest Expense 5-point trend, -96.2% · · $93.0K $106.0K $2M $2M $2M
Other Non-op 6-point trend, -86.2% $2M $12M $-29M $88M $-10M $12M ·
Pretax Income 7-point trend, -161.7% $-314M $-548M $-893M $-2.12B $-1.84B $-125M $-120M
Income Tax 7-point trend, -3904.5% $-837.0K $-479.0K $-71.0K $-15M $-1M $2M $22.0K
Net Income 7-point trend, -162.1% $-313M $-547M $-893M $-2.10B $-1.83B $-127M $-119M
EPS (Basic) 7-point trend, -5540.0% $-5.64 $-10.54 $-18.37 $-50.15 $-1.35 $-0.10 $-0.10
EPS (Diluted) 7-point trend, -5540.0% $-5.64 $-10.54 $-18.37 $-50.20 $-1.39 $-0.10 $-0.10
Shares (Basic) 7-point trend, -95.2% 55,457,676 51,894,639 48,610,507 41,976,537 1,359,849,000 1,274,766,915 1,149,000,417
Shares (Diluted) 7-point trend, -95.2% 55,457,676 51,894,639 48,610,507 41,995,972 1,360,373,000 1,274,766,915 1,149,000,417
EBITDA 4-point trend, +85.7% $-315M $-560M $-864M $-2.21B · · ·
Balance general 28
Datos anuales de Balance general para DNA
Métrica Tendencia 2025202420232022202120202019
Cash & Equivalents 7-point trend, -66.2% $167M $562M $944M $1.32B $1.55B $381M $495M
Short-term Investments 2-point trend, +255418000.00 $255M $0 · · · · ·
Receivables 6-point trend, +43.9% $24M $22M $17M $81M $132M $17M ·
Inventory 4-point trend, -98.3% · · $46.0K $4M $3M $3M ·
Prepaid Expense 6-point trend, +18.3% $25M $19M $40M $52M $34M $21M ·
Other Current Assets 4-point trend, -46.8% · · $362.0K $487.0K $698.0K $680.0K ·
Current Assets 6-point trend, +10.6% $472M $603M $1.00B $1.45B $1.72B $427M ·
PP&E (Net) 6-point trend, +37.8% $167M $204M $188M $315M $146M $121M ·
PP&E (Gross) 6-point trend, +128.9% $355M $365M $309M $408M $207M $155M ·
Accum. Depreciation 6-point trend, +456.3% $188M $161M $121M $93M $61M $34M ·
Goodwill 6-point trend, -100.0% · $0 $49M $60M $21M $2M $2M
Intangibles 6-point trend, +1523.6% $53M $73M $83M $111M $22M $3M ·
Other Non-current Assets 6-point trend, +61.1% $9M $55M $58M $89M $44M $6M ·
Total Assets 6-point trend, +65.8% $1.12B $1.38B $1.67B $2.54B $2.07B $675M ·
Accounts Payable 6-point trend, -23.9% $11M $14M $9M $10M $8M $14M ·
Accrued Liabilities 3-point trend, +276.0% · · · $115M $93M $31M ·
Short-term Debt · · · · · $300.0K ·
Current Liabilities 6-point trend, +31.1% $96M $107M $164M $173M $135M $73M ·
Capital Leases 5-point trend, +417078000.00 $417M $439M $222M $413M $0 · ·
Other Non-current Liabilities 6-point trend, +654.5% $23M $17M $24M $31M $36M $3M ·
Total Liabilities 6-point trend, +198.0% $611M $661M $568M $803M $504M $205M ·
Common Stock 6-point trend, -95.3% $6.0K $5.0K $5.0K $190.0K $161.0K $129.0K ·
Paid-in Capital 6-point trend, +616.5% $6.66B $6.56B $6.39B $6.14B $3.80B $929M ·
Retained Earnings 6-point trend, -1214.5% $-6.15B $-5.84B $-5.29B $-4.40B $-2.30B $-468M ·
AOCI 6-point trend, +1851000.00 $2M $-2M $1M $-3M $-2M $0 ·
Stockholders' Equity 6-point trend, +8.2% $509M $716M $1.10B $1.74B $1.57B $470M ·
Liabilities + Equity 6-point trend, +65.8% $1.12B $1.38B $1.67B $2.54B $2.07B $675M ·
Shares Outstanding 6-point trend, -95.5% 58,207,298 54,365,785,000 50,032,873 47,299,399 40,284,804 1,288,596,000 ·
Flujo de Efectivo 16
Datos anuales de Flujo de Efectivo para DNA
Métrica Tendencia 2025202420232022202120202019
D&A 7-point trend, +448.5% $59M $63M $71M $43M $29M $14M $11M
Stock-based Comp 7-point trend, +10476.7% $82M $112M $230M $1.93B $1.61B $476.0K $771.0K
Deferred Tax 6-point trend, -1364000.00 $-1M $-936.0K $-801.0K $-15M $0 $0 ·
Amort. of Intangibles 7-point trend, +3640.0% $19M $18M $16M $6M $1M $500.0K $500.0K
Restructuring 2-point trend, -41.1% $11M $19M · · · · ·
Operating Cash Flow 7-point trend, -283.0% $-171M $-320M $-296M $-252M $-254M $-136M $-45M
CapEx 7-point trend, -65.5% $8M $63M $41M $52M $57M $58M $22M
Investing Cash Flow 7-point trend, -222.1% $-240M $-62M $-81M $-67M $-73M $-67M $-75M
Stock Issued 3-point trend, +19469000.00 $19M $0 $0 · · · ·
Stock Repurchased · · · · · · $408.0K
Net Stock Activity $19M · · · · · ·
Financing Cash Flow 7-point trend, -95.7% $18M $-2M $-3M $95M $1.53B $90M $410M
Net Change in Cash 7-point trend, -235.1% $-393M $-384M $-380M $-223M $1.21B $-113M $291M
Taxes Paid 6-point trend, +192000.00 $192.0K $0 $23.0K $981.0K $9M $0 ·
Free Cash Flow 4-point trend, +41.3% $-179M $-382M $-336M $-304M · · ·
Levered FCF 2-point trend, -10.4% · · $-336M $-305M · · ·
Rentabilidad 7
Datos anuales de Rentabilidad para DNA
Métrica Tendencia 2025202420232022202120202019
Operating Margin 4-point trend, +59.9% -185.3% -246.5% -343.8% -462.4% · · ·
Net Margin 4-point trend, +58.3% -183.8% -240.9% -355.1% -440.6% · · ·
Pretax Margin 4-point trend, +58.5% -184.3% -241.2% -355.1% -444.1% · · ·
EBITDA Margin 4-point trend, +59.9% -185.3% -246.5% -343.8% -462.4% · · ·
ROA 4-point trend, +72.6% -25.1% -36.0% -42.5% -91.3% · · ·
ROE 4-point trend, +57.9% -55.8% -72.3% -76.0% -132.4% · · ·
ROIC 4-point trend, +51.1% -61.8% -78.1% -78.8% -126.3% · · ·
Liquidez y Solvencia 3
Datos anuales de Liquidez y Solvencia para DNA
Métrica Tendencia 2025202420232022202120202019
Current Ratio 4-point trend, -41.4% 4.9 5.6 6.1 8.4 · · ·
Quick Ratio 4-point trend, -42.4% 4.7 5.4 5.9 8.1 · · ·
Interest Coverage 2-point trend, +55.4% · · -9294.7 -20839.2 · · ·
Eficiencia 2
Datos anuales de Eficiencia para DNA
Métrica Tendencia 2025202420232022202120202019
Asset Turnover 4-point trend, -34.2% 0.1 0.1 0.1 0.2 · · ·
Receivables Turnover 4-point trend, +64.9% 7.4 11.6 5.1 4.5 · · ·
Por Acción 5
Datos anuales de Por Acción para DNA
Métrica Tendencia 2025202420232022202120202019
Book Value / Share 4-point trend, +852.1% $8.74 $13.17 $0.55 $0.92 · · ·
Revenue / Share 4-point trend, +978.8% $3.07 $4.38 $0.13 $0.28 · · ·
Cash Flow / Share 4-point trend, -1955.0% $-3.08 $-6.16 $-0.15 $-0.15 · · ·
Cash / Share 4-point trend, +313.0% $2.87 $10.33 $0.47 $0.70 · · ·
EPS (TTM) 5-point trend, -305.8% $-5.64 $-10.54 $-18.37 $-50.20 $-1.39 · ·
Tasas de Crecimiento 3
Datos anuales de Tasas de Crecimiento para DNA
Métrica Tendencia 2025202420232022202120202019
Revenue YoY 5-point trend, -108.1% -25.1% -9.7% -47.4% 52.2% 309.4% · ·
Revenue CAGR 3Y 3-point trend, -159.9% -29.1% -10.2% 48.6% · · · ·
Revenue CAGR 5Y 17.3% · · · · · ·
Valoración (TTM) 10
Datos anuales de Valoración (TTM) para DNA
Métrica Tendencia 2025202420232022202120202019
Revenue TTM 5-point trend, -45.8% $170M $227M $251M $478M $314M · ·
Net Income TTM 5-point trend, +82.9% $-313M $-547M $-893M $-2.10B $-1.83B · ·
Market Cap 4-point trend, -99.6% $484M $534M $135.29B $127.90B · · ·
P/E 5-point trend, +99.4% -1.5 -0.9 -3.7 -1.3 -239.1 · ·
P/S 4-point trend, -98.9% 2.8 2.4 538.0 267.7 · · ·
P/B 4-point trend, -98.7% 1.0 0.7 123.3 73.7 · · ·
P / Tangible Book 5-point trend, -99.7% 1.1 0.8 140.2 81.7 351.4 · ·
P / Cash Flow 4-point trend, +99.4% -2.8 -1.7 -457.8 -507.1 · · ·
P / FCF 4-point trend, +99.4% -2.7 -1.4 -402.3 -420.1 · · ·
Earnings Yield 5-point trend, -16059.5% -67.9% -107.3% -27.2% -74.3% -0.42% · ·

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

Estado de resultados
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ingresos $170M$227M$251M$478M$314M
Margen Operativo % -185.3%-246.5%-343.8%-462.4%
Beneficio neto $-313M$-547M$-893M$-2.10B$-1.83B
EPS Diluido $-5.64$-10.54$-18.37$-50.20$-1.39
Balance general
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ratio corriente 4.95.66.18.4
Ratio Rápido 4.75.45.98.1
Flujo de Efectivo
2025-12-312024-12-312023-12-312022-12-312021-12-31
Flujo de caja libre $-179M$-382M$-336M$-304M

Últimas noticias Noticias recientes que mencionan a esta empresa

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

📊

Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

Propietarios institucionales (13F) 204 declarantes · $269.0M total · A fecha de 30 de junio de 2026

Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.

Actividad institucional — Q2 2026 vs trimestre anterior
Nuevas posiciones Posiciones cerradas Aumentado Disminuido Cambio neto de acciones
39 (+13 vs trimestre anterior) 17 (-11 vs trimestre anterior) 65 (+23 vs trimestre anterior) 35 (-12 vs trimestre anterior) +6.2M

Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.

Institución Valor Acciones % de 13F rastreadas Tipo
VIKING GLOBAL INVESTORS LP $35 449 338 3 577 128 13,18% Acciones
Erste Asset Management GmbH $25 902 147 2 536 939 9,63% Acciones
BAILLIE GIFFORD & CO $23 701 242 2 391 649 8,81% Acciones
VANGUARD CAPITAL MANAGEMENT LLC $20 685 074 2 087 293 7,69% Acciones
Anchorage Capital Group, L.L.C. $17 306 457 1 746 363 6,43% Acciones
STATE STREET CORP $14 591 187 1 472 370 5,43% Acciones
GEODE CAPITAL MANAGEMENT, LLC $10 292 812 1 038 369 3,83% Acciones
VANGUARD PORTFOLIO MANAGEMENT LLC $9 293 628 937 803 3,46% Acciones
Allianz Asset Management GmbH $7 787 258 785 798 2,90% Acciones
MILLENNIUM MANAGEMENT LLC $6 329 279 638 676 2,35% Acciones
SB INVESTMENT ADVISERS (UK) LTD $6 052 324 610 729 2,25% Acciones
Prescott Group Capital Management, L.L.C. $5 369 684 541 845 2,00% Acciones
GOLDMAN SACHS GROUP INC $5 364 154 541 287 1,99% Acciones
RENAISSANCE TECHNOLOGIES LLC $5 349 973 539 856 1,99% Acciones
BANK OF AMERICA CORP /DE/ $4 760 754 480 399 1,77% Acciones
SUSQUEHANNA INTERNATIONAL GROUP, LLP $4 109 677 414 700 1,53% Opción de compra
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $3 910 555 394 607 1,45% Acciones
EXCHANGE TRADED CONCEPTS, LLC $3 555 540 358 783 1,32% Acciones
DIMENSIONAL FUND ADVISORS LP $3 480 392 351 200 1,29% Acciones
TUDOR INVESTMENT CORP ET AL $3 326 886 335 710 1,24% Acciones
VANGUARD FIDUCIARY TRUST CO $3 097 598 312 573 1,15% Acciones
Coastal Bridge Advisors, LLC $2 743 256 276 817 1,02% Acciones
BALANCE CAPITAL PARTNERS L.P. $1 972 179 199 009 0,73% Acciones
ALGERT GLOBAL LLC $1 784 395 180 060 0,66% Acciones
Susquehanna Portfolio Strategies, LLC $1 746 449 176 231 0,65% Acciones
BNP PARIBAS FINANCIAL MARKETS $1 637 935 165 281 0,61% Acciones
PEAK6 LLC $1 619 294 163 400 0,60% Opción de compra
CAXTON ASSOCIATES LLP $1 532 552 154 647 0,57% Acciones
D. E. Shaw & Co., Inc. $1 499 938 151 356 0,56% Acciones
Universal- Beteiligungs- und Servicegesellschaft mbH $1 387 400 140 000 0,52% Acciones
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1 297 219 130 900 0,48% Opción de venta
CITADEL ADVISORS LLC $1 233 973 124 518 0,46% Acciones
JPMORGAN CHASE & CO $1 154 383 113 064 0,43% Acciones
a16z Capital Management, L.L.C. $1 075 909 108 568 0,40% Acciones
CITADEL ADVISORS LLC $1 073 253 108 300 0,40% Opción de compra
Numerai GP LLC $1 036 606 104 602 0,39% Acciones
AMERICAN CENTURY COMPANIES INC $974 718 98 357 0,36% Acciones
WOLVERINE TRADING, LLC $964 467 72 900 0,36% Opción de compra
Ensign Peak Advisors, Inc $931 332 93 979 0,35% Acciones
Bank of New York Mellon Corp $818 843 82 628 0,30% Acciones
PANAGORA ASSET MANAGEMENT INC $803 592 81 089 0,30% Acciones
MARSHALL WACE, LLP $772 356 77 937 0,29% Acciones
Swiss National Bank $744 865 75 163 0,28% Acciones
ALLSTATE CORP $698 209 70 455 0,26% Acciones
Mariner, LLC $667 488 67 359 0,25% Acciones
IEQ CAPITAL, LLC $624 766 63 044 0,23% Acciones
ALLEN OPERATIONS LLC $613 935 61 951 0,23% Acciones
RHUMBLINE ADVISERS $610 615 61 617 0,23% Acciones
JACOBS LEVY EQUITY MANAGEMENT, INC $609 079 61 461 0,23% Acciones
TWO SIGMA INVESTMENTS, LP $599 099 60 454 0,22% Acciones
BROWN ADVISORY INC $586 731 59 206 0,22% Acciones
BlackRock, Inc. $526 895 53 168 0,20% Acciones
EDGEWOOD MANAGEMENT LLC $495 500 50 000 0,18% Acciones
WOLVERINE TRADING, LLC $492 156 37 200 0,18% Opción de venta
Quadrature Capital Ltd $456 732 46 088 0,17% Acciones
MORGAN STANLEY $447 427 45 149 0,17% Acciones
Shay Capital LLC $444 384 44 842 0,17% Acciones
LPL Financial LLC $427 257 43 114 0,16% Acciones
CITIGROUP INC $426 893 43 077 0,16% Acciones
JANE STREET GROUP, LLC $414 238 41 800 0,15% Opción de compra
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $387 709 39 123 0,14% Acciones
Casdin Capital, LLC $361 646 36 493 0,13% Acciones
CITADEL ADVISORS LLC $347 841 35 100 0,13% Opción de venta
Dynamic Technology Lab Private Ltd $347 000 34 996 0,13% Acciones
ALLIANCEBERNSTEIN L.P. $342 005 55 792 0,13% Acciones
GROUP ONE TRADING LLC $326 138 32 910 0,12% Acciones
AlphaQuest LLC $309 788 37 279 0,12% Acciones
Mitsubishi UFJ Asset Management Co., Ltd. $301 532 30 427 0,11% Acciones
Welch & Forbes LLC $297 300 30 000 0,11% Acciones
MetLife Investment Management, LLC $285 111 28 770 0,11% Acciones
AXQ CAPITAL, LP $262 387 26 477 0,10% Acciones
BARCLAYS PLC $258 919 26 127 0,10% Acciones
IMC-Chicago, LLC $240 922 24 311 0,09% Acciones
Man Group plc $239 901 24 208 0,09% Acciones
VANGUARD ASSET MANAGEMENT, Ltd $238 425 24 059 0,09% Acciones
CANADA PENSION PLAN INVESTMENT BOARD $222 975 22 500 0,08% Acciones
Russell Investments Group, Ltd. $222 885 22 491 0,08% Acciones
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $217 356 21 933 0,08% Acciones
Modera Wealth Management, LLC $216 316 21 828 0,08% Acciones
MARTINGALE ASSET MANAGEMENT L P $209 062 21 096 0,08% Acciones
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $203 116 22 345 0,08% Acciones
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $189 123 30 852 0,07% Acciones
Walleye Capital LLC $188 944 19 066 0,07% Acciones
Invesco Ltd. $186 209 18 790 0,07% Acciones
Trexquant Investment LP $178 420 18 004 0,07% Acciones
SIMPLEX TRADING, LLC $178 330 17 995 0,07% Acciones
Comprehensive Financial Management LLC $174 971 17 656 0,07% Acciones
SUSQUEHANNA INTERNATIONAL GROUP, LLP $172 474 17 404 0,06% Acciones
Boston Standard Wealth Management, LLC $164 995 15 165 0,06% Acciones
DEUTSCHE BANK AG\ $163 763 16 525 0,06% Acciones
Creative Planning $156 974 15 840 0,06% Acciones
Vanguard Global Advisers, LLC $155 904 15 732 0,06% Acciones
Squarepoint Ops LLC $155 478 15 689 0,06% Acciones
MERCER GLOBAL ADVISORS INC /ADV $153 664 15 506 0,06% Acciones
ExodusPoint Capital Management, LP $148 343 14 969 0,06% Acciones
Police & Firemen's Retirement System of New Jersey $146 420 14 775 0,05% Acciones
Entropy Technologies, LP $138 423 13 968 0,05% Acciones
Green Alpha Advisors, LLC $134 241 13 546 0,05% Acciones
VANGUARD GROUP INC $130 733 15 732 0,05% Acciones
MANUFACTURERS LIFE INSURANCE COMPANY, THE $127 690 12 885 0,05% Acciones

Informantes de la empresa 17 insiders · 5 directivos · 13 consejeros

Insider Rol Última actividad Acciones en propiedad Compras 12m Ventas 12m Neto 12m
Jason R Kelly Chief Executive Officer & Founder 28 de julio de 2026 A 3 894 680 0 0 $0
Steven P. Coen Chief Financial Officer 16 de julio de 2026 M 51 438 0 1 $-5 941
Mark E. Dmytruk Chief Financial Officer 20 de mayo de 2025 M 46 226 0 0 $0
Reshma P. Shetty President & Founder 28 de julio de 2026 A 12 374 544 0 0 $0
Marie E. Fallon Chief Accounting Officer 1 de mayo de 2023 M 183 010 0 0 $0
Sri Kosuri Consejero 11 de junio de 2026 A 24 067 0 0 $0
Ross Fubini Consejero 11 de junio de 2026 A 10 822 0 0 $0
Christian O Henry Consejero 11 de junio de 2026 A 24 310 0 2 $-219 800
Harry Sloan Consejero 11 de junio de 2026 A 271 418 0 0 $0
Shyam Sankar Consejero 12 de junio de 2025 A 72 372 0 0 $0
Kathy Hopinkah Hannan Consejero 11 de junio de 2025 M 15 003 0 0 $0
Myrtle S Potter Consejero 11 de junio de 2025 M 10 822 0 0 $0
Arie Belldegrun Consejero 13 de junio de 2024 A 194 925 0 0 $0
Reshma Kewalramani Consejero 12 de junio de 2024 M 186 002 0 0 $0
Marijn E Dekkers Consejero 12 de junio de 2024 M 386 480 0 0 $0
Eagle Equity Partners III, LLC Consejero 16 de septiembre de 2021 D 31 590 948 0 0 $0
Barry Canton Propietario del 10% 28 de julio de 2026 A 12 374 544 0 0 $0

Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto

Activistas y propietarios del %+ 5 4 tenencias

Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.

Declarante Presentado Participación Estado Propósito Presentación
Reshma P. Shetty, Barry Canton 14 de febrero de 2025 9,50% Enmienda SEC
Jason Kelly ×4 presentaciones 14 de febrero de 2024 Presentación inicial SEC
Reshma Shetty, Bartholomew Canton ×4 presentaciones 14 de febrero de 2024 Presentación inicial SEC
VIKING GLOBAL INVESTORS LP, VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, O. ANDREAS HALVORSEN, DAVID C. OTT, ROSE S. SHABET ×3 presentaciones 4 de marzo de 2022 Presentación inicial SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Propiedad de ETFs Mantenido por 33 ETFs

El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.

Fondo Ponderación Unidades A fecha de Fuente
THNQ · EXCHANGE TRADED CONCEPTS TRUST 0,84% 321 721 NS 30 de abril de 2026 N-PORT
IDNA · iShares Trust 0,44% 101 324 SH 8 de agosto de 2026 Diario
IWC · iShares Trust 0,09% 161 981 SH 8 de agosto de 2026 Diario
PRFZ · Invesco Exchange-Traded Fund Trust 0,05% 187 206 SH 8 de agosto de 2026 Diario
IBB · iShares Trust 0,03% 368 167 SH 8 de agosto de 2026 Diario
AVSC · AMERICAN CENTURY ETF TRUST 0,03% 91 425 NS 31 de mayo de 2026 N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS 0,03% 41 498 SH 8 de agosto de 2026 Diario
IWN · iShares Trust 0,03% 442 118 SH 8 de agosto de 2026 Diario
IWM · iShares Trust 0,01% 1 226 249 SH 8 de agosto de 2026 Diario
RSSL · Global X Funds 0,01% 18 139 NS 30 de abril de 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,01% 549 889 SH 8 de agosto de 2026 Diario
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 274 008 SH 8 de agosto de 2026 Diario
ITWO · ProShares Trust 0,01% 2 005 NS 31 de mayo de 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,01% 112 735 SH 8 de agosto de 2026 Diario
SCHA · SCHWAB STRATEGIC TRUST 0,01% 210 534 NS 31 de mayo de 2026 N-PORT
UWM · ProShares Trust 0,01% 1 567 NS 31 de mayo de 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0,01% 16 982 NS 30 de abril de 2026 N-PORT
URTY · ProShares Trust 0,00% 1 584 NS 31 de mayo de 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,00% 2 081 NS 31 de mayo de 2026 N-PORT
DFSU · Dimensional ETF Trust 0,00% 4 528 NS 30 de abril de 2026 N-PORT
HDG · ProShares Trust 0,00% 40 NS 31 de mayo de 2026 N-PORT
VEGN · ETF Series Solutions 0,00% 252 NS 30 de abril de 2026 N-PORT
DFAS · Dimensional ETF Trust 0,00% 19 123 NS 30 de abril de 2026 N-PORT
IWV · iShares Trust 0,00% 22 130 SH 8 de agosto de 2026 Diario
ITOT · iShares Trust 0,00% 66 432 SH 8 de agosto de 2026 Diario
SCHB · SCHWAB STRATEGIC TRUST 0,00% 26 477 NS 31 de mayo de 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 3 795 NS 30 de abril de 2026 N-PORT
DCOR · Dimensional ETF Trust 0,00% 584 NS 30 de abril de 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 1 182 NS 30 de abril de 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,00% 1 489 851 SH 8 de agosto de 2026 Diario
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 3 264 SH 8 de agosto de 2026 Diario
AVUS · AMERICAN CENTURY ETF TRUST 0,00% 504 NS 31 de mayo de 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 1 232 NS 30 de abril de 2026 N-PORT